Literature DB >> 2295937

MIBG scintigraphic assessment of cardiac adrenergic activity in response to altitude hypoxia.

J P Richalet1, P Merlet, M Bourguignon, J L Le-Trong, A Kéromès, C Rathat, B Jouve, M A Hot, A Castaigne, A Syrota.   

Abstract

High altitude hypoxia induces a decrease in the cardiac chronotropic function at maximal exercise or in response to isoproterenol infusion, suggesting an alteration in the cardiac sympathetic activation. Iodine-123 metaiodobenzylguanidine [( 123I]MIBG) was used to map scintigraphically the cardiac sympathetic neuronal function in six male subjects (aged 32 +/- 7 yr) after an exposure to high altitude that created hypoxic conditions. Results obtained just after return to sea level (RSL) were compared with the normal values obtained after 2 or 3 mo of normoxia (N). A static image was created as the sum of the 16-EKG gated images recorded for 10 min in the anterior view of the chest at 20, 60, 120, and 240 min after injection. Regions of interest were located over the heart (H), lungs (L), and mediastinum (M) regions. There was a significant decrease in the H/M and the L/M ratios in RSL compared to N condition. Plasma norepinephrine concentration was elevated during the stay at altitude but not significantly different in RSL compared to N. In conclusion, cardiac [123I]MIBG uptake is reduced after an exposure to altitude hypoxia, supporting the hypothesis of an hypoxia-induced reduction of adrenergic neurotransmitter reserve in the myocardium. Furthermore, the observed significant decrease in pulmonary MIBG uptake suggests an alteration of endothelial cell function after exposure to chronic hypoxia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295937

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

Review 1.  Nuclear medicine to image applied pathophysiology: evaluation of reserves by emission computerized tomography.

Authors:  U Buell; H Schicha
Journal:  Eur J Nucl Med       Date:  1990

2.  I-123 metaiodobenzylguanidine innervation imaging as a tool for norepinephrine transporter research: A possible application for genetic analysis in heart failure.

Authors:  Kenichi Nakajima; Ichiro Matsunari; Arnold F Jacobson
Journal:  J Nucl Cardiol       Date:  2016-11-28       Impact factor: 5.952

Review 3.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

4.  Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging.

Authors:  Koichi Okuda; Kenichi Nakajima; Tetsuo Hosoya; Takehiro Ishikawa; Takahiro Konishi; Kosuke Matsubara; Shinro Matsuo; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2010-11-23       Impact factor: 5.952

Review 5.  Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease.

Authors:  P Merlet; H Valette; J L Dubois-Randé; K Mardon; F Pouillart; M L Bourachot; A Castaigne; A Syrota
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

6.  Sympathetic innervation of the left ventricle is impaired in arrhythmogenic right ventricular disease.

Authors:  H Lerch; P Bartenstein; T Wichter; G Hindricks; M Borggrefe; G Breithardt; O Schober
Journal:  Eur J Nucl Med       Date:  1993-03

7.  Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography.

Authors:  C Guertner; H Klepzig; F D Maul; A Hartmann; S Lelbach; A Hellmann; G Hoer
Journal:  Eur J Nucl Med       Date:  1993-09

8.  Influence of prolonged exercise on myocardial distribution of 123I-MIBG in long-distance runners.

Authors:  M Estorch; R Serra-Grima; I Carrió; A Flotats; A Lizárraga; L L Bernà; T Prats; R Segura
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

9.  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.

Authors:  Kenichi Nakajima; Kosuke Matsubara; Takehiro Ishikawa; Nobutoku Motomura; Ryo Maeda; Nasima Akhter; Koichi Okuda; Junichi Taki; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

10.  Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging.

Authors:  Angelo Silverio; Maria Vincenza Polito; Leonardo Pace; Federica D'Auria; Gennaro Vitulano; Massimo Scarano; Rodolfo Citro; Gennaro Galasso; Federico Piscione
Journal:  J Nucl Cardiol       Date:  2019-02-13       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.